Richard E Lowenthal - Net Worth and Insider Trading
Richard E Lowenthal Net Worth
The estimated net worth of Richard E Lowenthal is at least $97 Million dollars as of 2024-06-21. Richard E Lowenthal is the PRESIDENT AND CEO, 10% Owner of ARS Pharmaceuticals Inc and owns about 12,565,600 shares of ARS Pharmaceuticals Inc (SPRY) stock worth over $97 Million. Details can be seen in Richard E Lowenthal's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard E Lowenthal has not made any transactions after 2024-06-12 and currently still holds the listed stock(s).
Transaction Summary of Richard E Lowenthal
Richard E Lowenthal Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard E Lowenthal owns 2 companies in total, including Silverback Therapeutics Inc (SBTX) , and ARS Pharmaceuticals Inc (SPRY) .
Click here to see the complete history of Richard E Lowenthal’s form 4 insider trades.
Insider Ownership Summary of Richard E Lowenthal
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SBTX | Silverback Therapeutics Inc | 2022-11-08 | director & 10 percent owner & President and CEO |
| SPRY | ARS Pharmaceuticals Inc | 2024-06-12 | director & 10 percent owner & President and CEO |
Richard E Lowenthal Latest Holdings Summary
Richard E Lowenthal currently owns a total of 1 stock. Richard E Lowenthal owns 12,565,600 shares of ARS Pharmaceuticals Inc (SPRY) as of June 12, 2024, with a value of $97 Million.
Latest Holdings of Richard E Lowenthal
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals Inc | 2024-06-12 | 12,565,600 | 7.74 | 97,257,744 |
Holding Weightings of Richard E Lowenthal
Richard E Lowenthal Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard E Lowenthal has made a total of 10 transactions in ARS Pharmaceuticals Inc (SPRY) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in ARS Pharmaceuticals Inc is the sale of 100,000 shares on June 12, 2024, which brought Richard E Lowenthal around $914,000.
Insider Trading History of Richard E Lowenthal
- 1
Richard E Lowenthal Trading Performance
Richard E Lowenthal Ownership Network
Richard E Lowenthal Owned Company Details
What does Silverback Therapeutics Inc do?
Who are the key executives at Silverback Therapeutics Inc?
Richard E Lowenthal is the director & 10 percent owner & President and CEO of Silverback Therapeutics Inc. Other key executives at Silverback Therapeutics Inc include Chief Operating Officer Brian Dorsey , Chief Legal Officer Alexander A Fitzpatrick , and Chief Financial Officer Kathleen D. Scott .
Silverback Therapeutics Inc (SBTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Silverback Therapeutics Inc (SBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Silverback Therapeutics Inc (SBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Silverback Therapeutics Inc (SBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Silverback Therapeutics Inc Insider Transactions
Richard E Lowenthal Mailing Address
Above is the net worth, insider trading, and ownership report for Richard E Lowenthal. You might contact Richard E Lowenthal via mailing address: 12481 High Bluff Drive, Suite 200, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
